Effects of halogenated antibacterials on the erythrocyte membrane

Chemico-biological Interactions
T L MillerD R Buhler

Abstract

The influence of halogenated antibacterials on membrane structure and function was investigated using the human erythrocyte membrane as a model. Measurements of hemolysis in isotonic solution, altered membrane permeability, and stabilization against hypotonic hemolysis resulting from exposure of erythrocytes to halogenated antibacterials served as criteria of membrane-related effects. The hemolytic potency of the compounds studied differed widely, decreasing in the order hexachlorophene (HCP) greater than 2,2'-methylenebis(3,5-dichlorophenol) (3,5-TCP) greater than 2,2'-methylenebis(3,4-dichlorophenol) (3,4-TCP) approximately equal to 2,2'-methylenebis(4,6-dichlorophenol) (4,6-TCP) greater than 2,2'-methylenebis(4-chlorophenol) (DCP) greater than 3,4'-tribromosalicylanilide (TBS) approximately equal to 3,3',4',5-tetrachlorosalicylanilide (TCSA). Each of the antibacterials tested stabilized the erythrocyte against hypotonic hemolysis, although there were marked differences in the concentrations required to afford maximum stabilization as well as in the extent of protection. The observed order of protective effectiveness was HCP greater than 3,4-TCP greater than 4,6-TCP greater than DCP approximately equal to TCS greater than TBS...Continue Reading

References

Jan 1, 1974·CRC Critical Reviews in Toxicology·R D Kimbrough
Jul 15, 1974·Biochemical Pharmacology·A J GandolfiD R Buhler
Aug 15, 1972·Biochemical Pharmacology·H S NakaueD R Buhler
Feb 2, 1971·Biochimica Et Biophysica Acta·K S Cho, P Proulx
Oct 1, 1971·Journal of Bacteriology·H L JoswickP Gerhardt
Sep 15, 1972·Biochemical Pharmacology·R S CaldwellD R Buhler
Sep 1, 1973·Archives of Neurology·P V De Jesus, D E Pleasure
Dec 1, 1974·Proceedings of the National Academy of Sciences of the United States of America·V G BieriP S Lin
Feb 1, 1974·Chemico-biological Interactions·T R Corner
Jul 1, 1974·Biochemical Pharmacology·G Flores, D R Buhler
Nov 1, 1974·Proceedings of the National Academy of Sciences of the United States of America·M P Sheetz, S J Singer
Jun 1, 1973·The Journal of Pediatrics·H PowellP Lampert
Jan 1, 1973·Acta Neuropathologica·P LampertR Garrett
Jan 1, 1974·Acta Neuropathologica·A J MartinezM G Hadfield
Oct 1, 1971·Journal of Bacteriology·T R CornerP Gerhardt
Mar 10, 1972·Biochemical and Biophysical Research Communications·W Cammer, C L Moore
Jul 20, 1971·Biochemistry·D F WilsonM S Koppelman
Aug 1, 1971·Archives of Environmental Health·R D Kimbrough, T B Gaines
Sep 1, 1966·Journal of General Microbiology·R C Woodroffe, B E Wilkinson
Nov 1, 1955·The Biochemical Journal·W N ALDRIDGE, J E CREMER
Apr 8, 1958·Proceedings of the Royal Society of London. Series B, Containing Papers of a Biological Character·E RIDEAL, F H TAYLOR

❮ Previous
Next ❯

Citations

Jul 1, 1983·Biulleten' eksperimental'noĭ biologii i meditsiny·F I BraginskaiaO M Zorina
Jun 1, 1993·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·D Agrawal, P Sultana
Jan 1, 1980·Journal of Toxicology and Environmental Health·T L Miller, M L Deinzer
Oct 1, 1981·Journal of Toxicology and Environmental Health·J L Wang, D R Buhler
May 28, 2004·International Journal of Toxicology·Torill A Yamarik
Jun 1, 1984·Annals of the Rheumatic Diseases·E J BatesC J Handley

❮ Previous
Next ❯

Related Concepts

Related Feeds

22q11 Deletion Syndrome

22q11.2 deletion syndrome, also known as DiGeorge syndrome, is a congenital disorder caused by a partial deletion of chromosome 22. Symptoms include heart defects, poor immune system function, a cleft palate, complications related to low levels of calcium in the blood, and delayed development. Discover the latest research on this disease here.